e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Biomarkers in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessment of ATP degradation in bronchoalveolar lavage fluid
Z. Lazar, M. Braun, A. Meyer, J. Beckert, I. Horvath, M. Idzko (Freiburg, Germany; Budapest, Hungary)
Source:
Annual Congress 2013 –Biomarkers in asthma and COPD
Session:
Biomarkers in asthma and COPD
Session type:
Oral Presentation
Number:
398
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Lazar, M. Braun, A. Meyer, J. Beckert, I. Horvath, M. Idzko (Freiburg, Germany; Budapest, Hungary). Assessment of ATP degradation in bronchoalveolar lavage fluid. Eur Respir J 2013; 42: Suppl. 57, 398
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ANCA associated vasculitis and lung disease
Management of severe community acquired pneumonia – ERS guidelines
Panel discussion on genetics in pulmonary fibrosis
Related content which might interest you:
The use of bronchoalveolar lavage (BAL) to assess lower airways inflammation in asthma
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Bronchoalveolar lavage tryptase levels are correlated with type 2 airway inflammation in mild asthma
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Determinants of oxidants load in broncho-alveiolar milieu
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Are there differences in the bronchoalveolar lavage (BAL) cytokine profile in children with and without allergic asthma?
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Periostin in lower airway samples and serum, a novel asthma marker?
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
Lipid mediator levels evidence gender-specific increases in bronchoalveolar lavage fluid of COPD patients relative to healthy smokers
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013
Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
Lung microbiome is associated with asthma severity in fungal associated asthma
Source: International Congress 2015 – Phenotyping asthma with biomarkers
Year: 2015
Investigation of mitochondria homeostasis and mitophagy in bronchoalveolar lavage fluid (BALF) cells in pulmonary fibrosis
Source: International Congress 2015 – IPF pathogenesis
Year: 2015
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Involvement of the JAK-STAT3 pathway in a lipopolysaccharide-induced rat model of airway inflammation
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013
Refractory severe asthma: Is presence of aspergillus in broncho-alveolar lavage significant?
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015
Surfactant protein D and its oligomeric forms in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
The value of bronchoalveolar lavage in the diagnosis and management of small airway disease
Source: International Congress 2014 – Clinical management of interstitial lung diseases and vasculitis
Year: 2014
Cytologicalfeaturesof bronchoalveolar lavage in different variants of exogenous allergic alveolitis
Source: International Congress 2014 – ILDs 5
Year: 2014
Activin –A and follistatin in sputum supernatant and BAL in patients with asthma
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
Elevated Tryptase concentration In bronchoalveolar lavage fluid from patients with chronic eosinophilic pneumonia
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Levels of antimicrobial peptide LL-37 in BALF and ELF from patients with pulmonary fibrosis
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept